T A Medsger

Author PubWeight™ 234.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988 16.45
2 Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997 6.10
3 Criteria for the classification of early systemic sclerosis. J Rheumatol 2001 5.39
4 Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med 2000 4.07
5 Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1994 3.24
6 Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000 3.02
7 Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988 2.93
8 Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 1989 2.67
9 Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study. Arthritis Rheum 1994 2.41
10 Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 1995 2.38
11 Long-term outcomes of scleroderma renal crisis. Ann Intern Med 2000 2.27
12 The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997 2.21
13 Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum 1984 2.17
14 Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 1980 2.13
15 Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 1994 2.11
16 Adult-onset Still's disease. Clinical course and outcome. Arthritis Rheum 1987 2.11
17 Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 1990 2.03
18 Eosinophilic fasciitis. A pathologic study of twenty cases. Am J Pathol 1979 2.02
19 Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 1971 2.00
20 The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 1998 1.97
21 Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. Arthritis Rheum 2000 1.97
22 Raynaud's phenomenon: a proposal for classification. Clin Exp Rheumatol 1993 1.96
23 Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 1991 1.94
24 Epidemiology of systemic sclerosis (scleroderma). Ann Intern Med 1971 1.93
25 Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 1993 1.91
26 D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis. Ann Intern Med 1982 1.84
27 Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum 2000 1.82
28 Carpal arthritis with ankylosis in late onset Still's disease. Arthritis Rheum 1976 1.82
29 The palpable tendon friction rub: an important physical examination finding in patients with systemic sclerosis. Arthritis Rheum 1997 1.78
30 Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study. Arthritis Rheum 1995 1.78
31 High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum 1999 1.75
32 Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986 1.72
33 Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis 2006 1.70
34 A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 1982 1.62
35 Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum 1988 1.54
36 Palmar fasciitis and polyarthritis associated with ovarian carcinoma. Ann Intern Med 1982 1.51
37 A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 1982 1.51
38 The epidemiology of polymyositis. Am J Med 1970 1.50
39 Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med 1994 1.50
40 The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis. Ann Intern Med 1967 1.45
41 Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum 1999 1.45
42 Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 1998 1.45
43 Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheum 1985 1.45
44 Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases. Medicine (Baltimore) 1983 1.44
45 Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease. Arthritis Rheum 1985 1.42
46 The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum 2001 1.42
47 Factors affecting survivorship in polymyositis. A life-table study of 124 patients. Arthritis Rheum 1971 1.40
48 Photopheresis for scleroderma? No! J Rheumatol 1992 1.40
49 D-penicillamine in the treatment of localized scleroderma. Arch Dermatol 1990 1.39
50 Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol 1990 1.37
51 A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 1990 1.35
52 Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum 1984 1.35
53 Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum 1992 1.33
54 Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 2001 1.31
55 Clinical spectrum of connective tissue disease after cosmetic surgery. Observations on eighteen patients and a review of the Japanese literature. Arthritis Rheum 1984 1.30
56 The rheumatic manifestaions of progressive systemic sclerosis (scleroderma). Clin Orthop Relat Res 1968 1.30
57 Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-control follow-up study. Am J Med 1987 1.26
58 Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med 1984 1.26
59 Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med 1984 1.26
60 Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients. J Chronic Dis 1973 1.24
61 Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum 1992 1.23
62 Epidemiology and natural history of systemic sclerosis. Rheum Dis Clin North Am 1990 1.23
63 Subacute sensory neuronopathy secondary to dorsal root ganglionitis in primary Sjögren's syndrome. Ann Neurol 1986 1.22
64 Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum 1985 1.21
65 Herpes zoster in systemic lupus erythematosus. J Rheumatol 1995 1.21
66 Skeletal muscle involvement in progressive systemic sclerosis (scleroderma). Arthritis Rheum 1968 1.17
67 Anemia and scleroderma: frequency, causes, and marrow findings. Arch Intern Med 1968 1.17
68 Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum 1999 1.16
69 Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982. Arthritis Rheum 1997 1.14
70 Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum 1994 1.13
71 Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association. Am Heart J 1993 1.12
72 Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol 1987 1.11
73 The toxicity of D-penicillamine in systemic sclerosis. Ann Intern Med 1986 1.11
74 Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol 1997 1.10
75 Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum 2000 1.09
76 Identification of autoantibodies to RNA polymerase II. Occurrence in systemic sclerosis and association with autoantibodies to RNA polymerases I and III. J Clin Invest 1993 1.08
77 Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations. Arthritis Rheum 1992 1.07
78 Anti-SS-A antibodies and fetal outcome in maternal systemic lupus erythematosus. Arthritis Rheum 1986 1.07
79 Normotensive renal failure in systemic sclerosis. Arthritis Rheum 1989 1.06
80 Tryptophan-induced eosinophilia-myalgia syndrome. N Engl J Med 1990 1.06
81 Prognostic importance of cardiac arrhythmias in systemic sclerosis. Am J Med 1988 1.05
82 Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study. Arthritis Rheum 1998 1.05
83 Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). Arthritis Rheum 1996 1.04
84 Autoantibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis. Arthritis Rheum 1990 1.03
85 Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma. Chest 1983 1.03
86 Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody. J Rheumatol 1996 1.03
87 Systemic lupus erythematosus in a boy with chronic granulomatous disease: case report and review of the literature. Arthritis Rheum 1991 1.02
88 Systemic sclerosis secondary to occupational exposure. Am J Med 1988 1.02
89 Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity. Arthritis Rheum 1996 1.01
90 Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. Lupus 1995 1.01
91 Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med 1986 0.99
92 Risk of malignancy in women with systemic lupus erythematosus. J Rheumatol 1995 0.98
93 Thyroid disease in progressive systemic sclerosis: increased frequency of glandular fibrosis and hypothyroidism. Ann Intern Med 1981 0.98
94 A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis/dermatomyositis. Arthritis Rheum 1990 0.98
95 Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study. Arthritis Rheum 1988 0.98
96 Vasculitis in systemic sclerosis: association with Sjögren's syndrome and the CREST syndrome variant. J Rheumatol 1987 0.98
97 Fertility and pregnancy outcome in women with systemic sclerosis. Arthritis Rheum 1999 0.98
98 A controlled study of the long-term prognosis of adult Still's disease. Am J Med 1995 0.97
99 Conclusion and identification of the core set of variables to be used in clinical investigations. Clin Exp Rheumatol 2003 0.96
100 Novel human autoantibodies reactive with 5'-terminal trimethylguanosine cap structures of U small nuclear RNA. J Immunol 1992 0.96
101 Massive breast enlargement in a patient receiving D-penicillamine for systemic sclerosis. J Rheumatol 1985 0.96
102 Classification and diagnostic criteria for polymyositis and dermatomyositis. J Rheumatol 1995 0.95
103 Cytokine production and serum levels in systemic sclerosis. Clin Immunol Immunopathol 1992 0.95
104 Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis. J Lab Clin Med 1986 0.94
105 The electrocardiogram in systemic sclerosis (scleroderma). Study of 102 consecutive cases with functional correlations and review of the literature. Am J Med 1985 0.94
106 Hydralazine induced lupus and Sweet's syndrome. Report and review of the literature. J Rheumatol 1990 0.94
107 Proceedings: Eosinophilic fasciitis. Report of six cases of a newly recognized scleroderma-like syndrome. Arthritis Rheum 1976 0.93
108 T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors. J Clin Invest 1995 0.93
109 Antiphospholipid antibodies in pediatric systemic lupus erythematosus. Pediatrics 1995 0.92
110 Newly identified U4/U6 snRNP-binding proteins by serum autoantibodies from a patient with systemic sclerosis. J Immunol 1991 0.92
111 Immune complexes in progressive systemic sclerosis (scleroderma). Arthritis Rheum 1982 0.91
112 The effect of D-penicillamine on pulmonary findings in systemic sclerosis. Arthritis Rheum 1985 0.91
113 Surgery for scleroderma of the hand. J Hand Surg Am 1987 0.91
114 Trigeminal neuropathy in progressive systemic sclerosis. Am J Med 1982 0.91
115 Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele. Hum Immunol 1994 0.90
116 Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma). J Clin Immunol 1982 0.90
117 Brachial plexitis mimicking C5 radiculopathy--a presentation of giant cell arteritis. J Rheumatol 1983 0.89
118 HLA-DR antigens in progressive systemic sclerosis (scleroderma). J Rheumatol 1983 0.89
119 Hypocalcemia associated with metastatic bone disease. A retrospective study. Arch Intern Med 1973 0.89
120 Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin). J Rheumatol 2000 0.89
121 Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis. Arthritis Rheum 1996 0.89
122 A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis. Arthritis Rheum 1995 0.89
123 Anti-U5 small nuclear ribonucleoprotein (snRNP) antibodies: a rare anti-U snRNP specificity. Clin Immunol Immunopathol 1996 0.88
124 T and B cell collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis. J Immunol 1995 0.88
125 Cerebrospinal fluid immune complexes in systemic lupus erythematosus involving the central nervous system. Semin Arthritis Rheum 1982 0.88
126 High titers of antibodies to single-stranded DNA in linear scleroderma. Arch Dermatol 1985 0.88
127 Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis. J Am Acad Dermatol 1987 0.88
128 Alpha 1-antitrypsin phenotypes, including M subtypes, in pulmonary disease associated with rheumatoid arthritis and systemic sclerosis. Arthritis Rheum 1986 0.88
129 Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polymerase complexes. Arthritis Rheum 1999 0.87
130 Cutaneous hypoxia in patients with systemic sclerosis (scleroderma). Arch Dermatol 1988 0.87
131 Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis. Arthritis Rheum 1992 0.87
132 Pulmonary arterial histology and morphometry in systemic sclerosis: a case-control autopsy study. J Rheumatol 1989 0.86
133 HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies. Hum Immunol 1995 0.86
134 HLA and clinical associations in systemic sclerosis patients with anti-Th/To antibodies. Arthritis Rheum 1998 0.86
135 Soluble serum interleukin 2 receptors in patients with systemic sclerosis. J Rheumatol 1996 0.86
136 The epidemiology of systemic sclerosis (scleroderma) among male U.S. veterans. J Chronic Dis 1978 0.86
137 The assessment of the patient with systemic sclerosis. Introduction. Clin Exp Rheumatol 2003 0.86
138 Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis-dermatomyositis. J Rheumatol 1988 0.86
139 Systemic sclerosis and malignancy--are they related? J Rheumatol 1985 0.85
140 Pregnancy in women with systemic sclerosis. Arthritis Rheum 1989 0.85
141 Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial. Rheumatology (Oxford) 2001 0.85
142 Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis. Arthritis Rheum 2001 0.85
143 Functional and phenotypic analysis of T lymphocytes cloned from the skin of patients with systemic sclerosis. Clin Exp Immunol 1990 0.85
144 Prospective evaluation of thyroid function in patients with systemic sclerosis (scleroderma). J Rheumatol 1986 0.85
145 Resorption of the mandibular condyles and coronoid processes in progressive systemic sclerosis (scleroderma). Arthritis Rheum 1981 0.84
146 Serum antibody to retroviral gag proteins in systemic sclerosis. Arthritis Rheum 1991 0.84
147 Pasteurella multocida polyarticular septic arthritis. J Rheumatol 1987 0.84
148 Autoantibodies to mitochondria in systemic sclerosis. Frequency and characterization using recombinant cloned autoantigen. Arthritis Rheum 1988 0.83
149 Coronary arteritis in systemic lupus erythematosus. Chest 1976 0.83
150 A new look at the epidemiology of ankylosing spondylitis and related syndromes. Clin Orthop Relat Res 1979 0.83
151 Reduced natural killer cell activity in patients with systemic sclerosis. Correlation with clinical disease type. Arthritis Rheum 1988 0.83
152 Reduced T lymphoid colony growth in patients with progressive systemic sclerosis and rheumatoid arthritis. J Lab Clin Med 1982 0.83
153 Previous pregnancy outcome is an important determinant of subsequent pregnancy outcome in women with systemic lupus erythematosus. Am J Reprod Immunol 1993 0.83
154 The variability of immunologic laboratory tests. J Rheumatol 1982 0.83
155 Evidence of activation of 2 herpesviruses, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins. J Rheumatol 2000 0.82
156 Polymyositis and dermatomyositis in children: an epidemiologic and clinical comparative analysis. J Rheumatol 1982 0.82
157 Highly restricted TCR-alpha beta usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope. J Immunol 1997 0.82
158 Systemic sclerosis (scleroderma) and esophageal adenocarcinoma: Is increased patient screening necessary? Gastroenterology 1985 0.82
159 Serum eosinophilotactic activity in eosinophilic fasciitis. Arthritis Rheum 1982 0.82
160 Serum amyloid A protein concentration in progressive systemic sclerosis (scleroderma). Ann Rheum Dis 1984 0.82
161 Treatment of systemic sclerosis with recombinant interferon-gamma. A phase I/II clinical trial. Arthritis Rheum 1992 0.81
162 Endothelial dysfunction is present only in the microvasculature and microcirculation of early diffuse systemic sclerosis patients. Clin Exp Rheumatol 2014 0.81
163 Rigorous new approach to constructing a gold standard for validating new diagnostic criteria, as exemplified by the eosinophilia-myalgia syndrome. Arch Intern Med 2001 0.81
164 Risk factors for adult Still's disease. J Rheumatol 1996 0.81
165 Allergic granulomatous angiitis (Churg-Strauss syndrome). J Allergy Clin Immunol 1975 0.80
166 Serum immunoglobulins, rheumatoid factor, and pneumoconiosis in coal miners with rheumatoid arthritis. Arthritis Rheum 1976 0.80
167 D-penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma). Arthritis Rheum 1987 0.80
168 Proceedings: HL-A antigen 27 and psoriatic spondylitis. Arthritis Rheum 1974 0.80
169 Analysis of soluble and cell surface factors regulating anti-DNA topoisomerase I autoantibody production demonstrates synergy between Th1 and Th2 autoreactive T cells. J Immunol 2000 0.79
170 Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs. J Rheumatol 1993 0.79
171 Surgery for ischemic pain and Raynaud's' phenomenon in scleroderma: a description of treatment protocol and evaluation of results. Microsurgery 2001 0.79
172 Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. Exercise radionuclide evaluation and comparison with diffuse scleroderma. Am J Med 1984 0.79
173 Eosinophilia-myalgia syndrome not associated with the ingestion of nutritional supplements. J Rheumatol 1994 0.78
174 Systemic sclerosis with renal crisis and pulmonary hypertension: a report of eleven cases. Arthritis Rheum 2001 0.78
175 Inflammatory myopathies. Baillieres Clin Rheumatol 1995 0.78
176 Consensus statement on the relationship of breast implants to connective-tissue disorders. Plast Reconstr Surg 1992 0.77
177 Current management of polymyositis and dermatomyositis. Drugs 1989 0.77
178 Pregnancy outcome and anti-cardiolipin antibody in women with systemic lupus erythematosus. Am J Epidemiol 1993 0.77
179 Correlation between ANA determinations on tissue substrate, WiL-2 cell substrate, and precipitin antibody by double diffusion. Diagn Clin Immunol 1987 0.76
180 An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera. Arthritis Rheum 1999 0.76
181 Progressive systemic sclerosis. Clin Rheum Dis 1983 0.76
182 Scleromyxedema serum increases proliferation but not the glycosaminoglycan synthesis of dermal fibroblasts. J Rheumatol 1989 0.76
183 Circulating immune complexes in eosinophilic fasciitis. Arthritis Rheum 1982 0.76
184 Severe arthralgias after wide fluctuation in corticosteroid dosage. J Rheumatol 1986 0.75
185 Systemic sclerosis (scleroderma) and multiple sclerosis. Arthritis Rheum 1986 0.75
186 Microsurgical revascularisation of the hand in scleroderma. Br J Plast Surg 1987 0.75
187 We need simple guidelines for reporting rates of rheumatic diseases. Arthritis Rheum 1999 0.75
188 Scleromyxedema myopathy: case report and review of the literature. Arthritis Rheum 1988 0.75
189 Detection of anti-DNA topoisomerase I antibody by an enzyme-linked immunosorbent assay using overlapping recombinant polypeptides. Clin Immunol Immunopathol 1995 0.75
190 The Lupus Foundation as an additional source for case ascertainment: developing a community-based lupus registry. Arthritis Care Res 2000 0.75
191 Lipid microspherule-associated acute monarticular arthritis. Arthritis Rheum 1986 0.75
192 A novel cell-cycle-dependent 350-kDa nuclear protein: C-terminal domain sufficient for nuclear localization. Biochem Biophys Res Commun 1995 0.75
193 Response of patients with renal involvement by progressive systemic sclerosis to antihypertensive therapy. Clin Sci (Lond) 1981 0.75
194 Specificity of the hydrochloric-acid-modified Crithidia luciliae immunofluorescence assay for detection of antibody to native DNA. Diagn Clin Immunol 1987 0.75
195 Wrist drop in progressive systemic sclerosis (scleroderma): complete rupture of the extensor tendon mechanism. Arthritis Rheum 1985 0.75
196 Communicating hydrocephalus secondary to diffuse meningeal spread of Wegener's granulomatosis: case report and literature review. Neurosurgery 1998 0.75
197 Cholestasis associated with D-penicillamine therapy: case report and review of the literature. Arthritis Rheum 1981 0.75
198 Proceedings: Selective carpo-metacarpal arthritis with early ankylosis in adult onset Still's disease. Arthritis Rheum 1976 0.75
199 L-tryptophan-associated eosinophilic fasciitis prior to the 1989 eosinophilia-myalgia syndrome outbreak. Arthritis Rheum 1992 0.75
200 Isolated pulmonary hypertension in diffuse cutaneous systemic sclerosis successfully treated with long-term plasma exchange. Scand J Rheumatol 2000 0.75
201 Discordance of SSA/Ro and SSB/La cellular antigens in synchronized cells. J Invest Dermatol 1986 0.75